Literature DB >> 6572786

Variable bioavailability of oral mercaptopurine. Is maintenance chemotherapy in acute lymphoblastic leukemia being optimally delivered?

S Zimm, J M Collins, R Riccardi, D O'Neill, P K Narang, B Chabner, D G Poplack.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6572786     DOI： 10.1056/NEJM198304283081705

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  62 in total

Review 1.  The clinical pharmacology of 6-mercaptopurine.

Authors:  L Lennard
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  A phase II trial of continuous-infusion 6-mercaptopurine for childhood solid tumors.

Authors:  P C Adamson; S Zimm; A H Ragab; S M Steinberg; F Balis; B A Kamen; T J Vietti; A Gillespie; D G Poplack
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

Review 3.  Clinical pharmacokinetics-pharmacodynamics of anticancer drugs.

Authors:  W E Evans; M V Relling
Journal:  Clin Pharmacokinet       Date:  1989-06       Impact factor: 6.447

4.  Phase I study of BCNU and intravenous 6-mercaptopurine in patients with anaplastic gliomas.

Authors:  D C Smith; N A Vick; D L Trump; H S Friedman; A H Friedman; J Purvis; A Gauspari; S C Schold
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

5.  Infliximab exerts no direct hepatotoxic effect on HepG2 cells in vitro.

Authors:  Hilbert S de Vries; Tineke de Heij; Henie M J Roelofs; Rene H M te Morsche; Wilbert H M Peters; Dirk J de Jong
Journal:  Dig Dis Sci       Date:  2012-04-26       Impact factor: 3.199

Review 6.  Pharmacogenomics and personalized medicine: a review focused on their application in the Chinese population.

Authors:  Wen-ying Shu; Jia-li Li; Xue-ding Wang; Min Huang
Journal:  Acta Pharmacol Sin       Date:  2015-04-20       Impact factor: 6.150

7.  6-Thioguanine: high-dose 2-H infusions in goats.

Authors:  T J Schouten; R A De Abreu; E D Schretlen; M B van Leeuwen; J M van Baal; G A de Vaan
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

8.  Pharmacogenomic studies of the anticancer and immunosuppressive thiopurines mercaptopurine and azathioprine.

Authors:  Ahmed F Hawwa; Jeff S Millership; Paul S Collier; Koen Vandenbroeck; Anthony McCarthy; Sid Dempsey; Carole Cairns; John Collins; Colin Rodgers; James C McElnay
Journal:  Br J Clin Pharmacol       Date:  2008-06-28       Impact factor: 4.335

9.  Population pharmacokinetic and pharmacogenetic analysis of 6-mercaptopurine in paediatric patients with acute lymphoblastic leukaemia.

Authors:  Ahmed F Hawwa; Paul S Collier; Jeff S Millership; Anthony McCarthy; Sid Dempsey; Carole Cairns; James C McElnay
Journal:  Br J Clin Pharmacol       Date:  2008-09-23       Impact factor: 4.335

Review 10.  Use of allopurinol with low-dose 6-mercaptopurine in inflammatory bowel disease to achieve optimal active metabolite levels: a review of four cases and the literature.

Authors:  T N Witte; A L Ginsberg
Journal:  Can J Gastroenterol       Date:  2008-02       Impact factor: 3.522
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.